Xconomy Forum: What's Hot in Cancer Immunotherapy
AGENDA
2:00 – 2:45Registration
2:45 – 2:50Welcome & Opening Remarks
Xconomy and Fred Hutchinson Cancer Research Center
2:50 – 3:20Opening Keynote: What’s New in Immunotherapy?
Stan Riddell, Researcher, Fred Hutchinson Cancer Research Center
3:20 – 3:50Startup Presentations (10 minutes each)
Rob Hershberg
, CEO, VentiRx Pharmaceuticals
Martin Oft, VP, Clinical and Regulatory Affairs, ARMO BioSciences
Teresa Foy, CSO, Oncofactor Corporation
3:50 – 4:30Networking Break
4:30 – 4:50Startup Presentations (10 minutes each)
Chad Robins, CEO, Adaptive Biotechnologies
Mitch Gold, Executive Chairman, Alpine BioSciences
4:50 – 5:20Big Pharma’s Immunotherapy Push (15 minutes each)
Ira Mellman, VP, Cancer Immunology, Genentech

Deborah Law
, VP, Biologics Discovery, Merck
5:20 – 5:45Closing Keynote Chat
Hans Bishop, CEO, Juno Therapeutics
Robert Nelsen, Managing Director, Arch Venture Partners
Luke Timmerman, Xconomy (moderator)
5:45 – 7:00Networking Reception
REGISTER NOW: xconomyforum69.eventbrite.com